Company ERYTECH Pharma LIQUIDNET SYSTEMS
Equities
FR0011471135
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Thibaut du Fayet
CEO | Chief Executive Officer | 56 | 23/23/23 |
Eric Soyer
DFI | Director of Finance/CFO | 57 | 23/23/23 |
Pascal Birman
CTO | Chief Tech/Sci/R&D Officer | - | 23/23/23 |
Cindy Fevre
CTO | Chief Tech/Sci/R&D Officer | - | 23/23/23 |
Céline Breda
CTO | Chief Tech/Sci/R&D Officer | 54 | 23/23/23 |
Karine Charton
PRN | Corporate Officer/Principal | - | 23/23/23 |
General Counsel | - | 23/23/23 | |
Human Resources Officer | - | 23/23/23 | |
Jérôme Bailly
PRN | Corporate Officer/Principal | 45 | 23/23/23 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 23/23/23 | |
Hilde Windels
BRD | Director/Board Member | 59 | 23/23/23 |
Gil Beyen
BRD | Director/Board Member | 62 | 23/23/23 |
Martine George
BRD | Director/Board Member | 76 | 23/23/23 |
Director/Board Member | 66 | 23/23/23 | |
Didier Hoch
CHM | Chairman | 68 | 23/23/23 |
Leila Nicolas
BRD | Director/Board Member | - | 23/23/23 |
Robert Sebbag
BRD | Director/Board Member | 73 | 23/23/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 11,137,712 | 10,660,161 ( 95.71 %) | 270 ( 0.002429 %) | 95.71 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
250 | 0.00% | 813 $ |
Company contact information
![address ERYTECH Pharma](https://cdn.zonebourse.com/static/address/35055710.png)
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+16.61% | 12TCr | |
+17.75% | 11TCr | |
+17.23% | 2.59TCr | |
-24.11% | 1.93TCr | |
-18.56% | 1.62TCr | |
-18.47% | 1.56TCr | |
-47.75% | 1.46TCr | |
+57.35% | 1.43TCr | |
+5.62% | 1.4TCr |